Abiopharma

🔍 Ternus John (Executive)

Company: Apple Inc. (AAPL)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 7,690 shares of Restricted Stock Unit (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,690.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSUs") represents the right to receive, at settlement, one share of common stock.
• F2: This RSU award was granted September 1, 2026, with 12.5% of the RSUs scheduled to vest on March 15, 2027 and the remaining RSUs scheduled to vest 12.5% in semi-annual installments over a four-year period ending September 15, 2030, subject to the terms and conditions of the underlying award agreement.